✦ LIBER ✦

Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy

✍ Scribed by Paal Fr Brunsvig; Anders Andersen; Steinar Aamdal; Vessela Kristensen; Harald Olsen

Book ID: 115011068
Publisher: BioMed Central
Year: 2007
Tongue: English
Weight: 320 KB
Volume: 7
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-7-197

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose–Volume Analysis of Radiation Pneumo

Dose–Volume Analysis of Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated With Concurrent Cisplatinum and Etoposide With or Without Consolidation Docetaxel

✍ R. Bryan Barriger; Achilles J. Fakiris; Nasser Hanna; Menggang Yu; Prasad Mantra 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Docetaxel and concurrent radiotherapy af

Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer

✍ Vergnenègre, A.; Daniel, C.; Léna, H.; Fournel, P.; Kleisbauer, J.P.; Caer, H. L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Dose-finding, pharmacokinetic and phase

Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer

✍ Rebattu, Paul; Quantin, Xavier; Ardiet, Claude; Morere, Jean-François; Azarian, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Phase I trial of dose escalation of cape

Phase I trial of dose escalation of capecitabine combined with fixed docetaxel in previously treated patients with non-small cell lung cancer

✍ Qiang Lin; Yue’e Liu; Chuilin Chang; Na Wang; Jingmei Fu; Xiaocang Ren; Xueji Ch 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 260 KB

The risk of febrile neutropenia in patie

The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis

✍ Wailoo, A; Sutton, A; Morgan, A 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB